Cullinan oncology to present at the 42nd annual j.p. morgan healthcare conference

Cambridge, mass., dec. 18, 2023 (globe newswire) --  cullinan oncology, inc. (nasdaq: cgem) (“cullinan oncology”) a biopharmaceutical company focused on modality-agnostic targeted oncology therapies, today announced that chief executive officer, nadim ahmed, will present at the 42nd annual j.p. morgan healthcare conference, being held january 8-11, 2024 in san francisco, ca. mr. ahmed's presentation is scheduled for thursday, january 11, at 10:30 am pst (1:30 pm est).
CGEM Ratings Summary
CGEM Quant Ranking